Axel Hohenstein | Managing Director (CSO)
Reaction Biology

Axel joined Bioassay in 2007 as Scientists after covering the role of Laboratory Head of Department of Cell and Molecular Biology at Biotest AG. Upon joining Bioassay Axel quickly rose through the ranks and became Managing Director in 2010. In his new role he was involved in the acquisition of Peptide Specialty Laboratories GmbH by Bioassay which he successfully completed in 2017.
Axel earned his magna cum laude Doctorate from the University of Heidelberg, probing angiogenic factors in chronic subdural hematoma.
Immediately after graduating in Biotechnology from the University of Mannheim, Axel worked as Bio-Engineer at BRAIN AG where he perfected his assay development skills.
Axel’s extensive experience includes a profound understanding of GMP, GLP, and FDA approval processes, underscoring his commitment to maintaining the highest standards of quality and integrity. His collaborative approach and aptitude for fostering partnerships have enabled him to cultivate a global network of industry connections.
Axel is currently Managing Director and CSO at Bioassay.